Cite

HARVARD Citation

    Chey, W. et al. (2020). Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therapeutic advances in gastroenterology. p. . [Online]. 
  
Back to record